Borealis Biosciences, Inc.
Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Open Positions
1
Departments
1
Locations
1
Not specified
Borealis Biosciences is focused on developing RNA medicines to treat kidney diseases, addressing unmet needs in prevalent kidney diseases to improve patient lives globally. The company builds upon the success of Chinook Therapeutics and aims to transform kidney disease treatment through targeted RNA delivery.
Required Skills
- Expertise in kidney disease
- Targeted delivery of RNA therapeutics
- Translational systems biology
- Data sciences
- Translational biology
- Chemistry
- DMPK
- Pharmacology
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats